As of 2026-04-02, the Intrinsic Value of Shenzhen Mindray Bio-Medical Electronics Co Ltd (300760.SZ) is 142.55 CNY. This 300760.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 165.90 CNY, the upside of Shenzhen Mindray Bio-Medical Electronics Co Ltd is -14.10%.
The range of the Intrinsic Value is 115.40 - 193.29 CNY
Based on its market price of 165.90 CNY and our intrinsic valuation, Shenzhen Mindray Bio-Medical Electronics Co Ltd (300760.SZ) is overvalued by 14.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 115.40 - 193.29 | 142.55 | -14.1% |
| DCF (Growth 10y) | 138.08 - 224.37 | 168.46 | 1.5% |
| DCF (EBITDA 5y) | 270.58 - 378.46 | 332.72 | 100.6% |
| DCF (EBITDA 10y) | 260.98 - 388.42 | 328.23 | 97.9% |
| Fair Value | 147.25 - 147.25 | 147.25 | -11.24% |
| P/E | 185.99 - 259.65 | 220.86 | 33.1% |
| EV/EBITDA | 131.50 - 249.87 | 183.85 | 10.8% |
| EPV | 84.46 - 107.15 | 95.81 | -42.3% |
| DDM - Stable | 49.36 - 118.89 | 84.12 | -49.3% |
| DDM - Multi | 100.38 - 177.36 | 127.25 | -23.3% |
| Market Cap (mil) | 201,143.80 |
| Beta | 1.25 |
| Outstanding shares (mil) | 1,212.44 |
| Enterprise Value (mil) | 184,369.10 |
| Market risk premium | 6.13% |
| Cost of Equity | 9.72% |
| Cost of Debt | 5.00% |
| WACC | 9.71% |